Octreotide
Octreotide is a pharmaceutical drug with 66 clinical trials. Currently 3 active trials ongoing. Historical success rate of 80.8%.
Success Metrics
Based on 42 completed trials
Phase Distribution
Phase Distribution
11
Early Stage
18
Mid Stage
22
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
77.8%
42 of 54 finished
22.2%
12 ended early
3
trials recruiting
66
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
Treatment of Orthostatic Intolerance
Prevention of Postoperative Pancreatic Fistula by Somatostatin
Clinical Trials (66)
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
Treatment of Orthostatic Intolerance
Prevention of Postoperative Pancreatic Fistula by Somatostatin
Outcome of ADPKD With Octreotide LAR
A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide
Cattell-Warren Versus Blumgart Techniques of Pancreatico-jejunostomy Following Pancreato-duodenectomy
Treatment of Idiopathic Pulmonary Fibrosis with Long Acting Octreotide
Angiotensin 2 for Hepatorenal Syndrome
Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy
Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer
The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
Ghrelin Suppression by Octreotide in Prader-Willi
Palliative Management of Inoperable Malignant Bowel Obstruction
Investigation of the Effects of Obesity Surgery on Appetitive Behaviour
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 66